Centene to sell its continental European businesses to Vivalto Santé Another milestone in Centene's value creation program and ongoing portfolio review ST. LOUIS, July 25, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that as part of its previously announced review of strategic alternatives for its international portfolio, it has signed a definitive agreement to sell to Vivalto Santé its Spanish and Central European businesses, which include: "This transaction represents another significant milestone in our value creation plan and ongoing portfolio review," said Sarah London, CEO of Centene.